Table 2.
Spearman correlation analysis between RVE1 levels and clinical characteristics in all the participants
| Correlation coefficient | P value | |
|---|---|---|
| TT3 (ng/mL) | -0.348 | 0.008* |
| TT4 (µg/dL) | 0.011 | 0.934 |
| FT3 (pg/mL) | -0.339 | 0.010* |
| FT4 (ng/dL) | 0.146 | 0.278 |
| TSH (uIU/mL) | -0.019 | 0.891 |
| TgAb (U/mL) | -0.426 | 0.001* |
| TPOAb (U/mL) | -0.244 | 0.067 |
| Leukocyte levels (×109/L) | -0.083 | 0.645 |
| Hemoglobin (g/L) | -0.101 | 0.574 |
| Platelet count (×109/L) | -0.133 | 0.461 |
| Albumin (g/L) | 0.059 | 0.743 |
| ALT (U/L) | -0.001 | 0.996 |
| AST (U/L) | -0.153 | 0.396 |
| Serum potassium (mmol/L) | -0.157 | 0.391 |
| Serum sodium (mmol/L) | 0.273 | 0.130 |
| Blood glucose (mmol/L) | 0.249 | 0.169 |
| Creatinine (µmol/L) | 0.038 | 0.836 |
| BUN (mmol/L) | -0.207 | 0.256 |
| Uric acid (µmol/L) | -0.094 | 0.611 |
| TG (mmol/L) | 0.167 | 0.395 |
| TC (mmol/L) | -0.161 | 0.413 |
| HDL (mmol/L) | 0.062 | 0.752 |
| LDL (mmol/L) | -0.176 | 0.371 |
| CRP (mg/L) | -0.999 | 0.645 |
TT4 total T4; TT3 total T3; FT3 free T3; FT4 free T4; TSH thyroid-stimulating hormone; TPOAb anti-thyroperoxidase antibody; TgAb anti-thyroglobulin antibody; ALT alanine aminotransferase; AST aspartate aminotransferase; BUN blood urea nitrogen; TG triglyceride, TC total cholesterol; HDL high-density lipoprotein; LDL low-density lipoprotein; CRP C-reactive protein; *P < 0.05